FindTrial
Sign In

Artificial intelligence-based tool for early detection of cervical cancer using Pap smear and colposcopy images

AI-POWERED MULTIMODAL CERVICAL CANCER PRE-SCREENING TOOL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112367
Enrollment
508
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C538- Malignant neoplasm of overlappingsites of cervix uteri

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

MEDXAI INNOVATIONS PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women undergoing routine colposcopy and or Pap smear examination. Willing to provide written informed consent. Availability of usable colposcopy images and or Pap smear slides suitable for analysis.

Exclusion criteria

Exclusion criteria: Inability to provide informed consent. Poor quality images unsuitable for analysis. Pregnant women if clinically excluded from routine screening.

Design outcomes

Primary

MeasureTime frame
Diagnostic performance of the AI powered cervical pre screening tool in detecting cervical pre cancerous lesions measured by accuracy sensitivity and specificity against expert clinical interpretation and cytopathology reports.Timepoint: At baseline during the screening visit.—

Secondary

MeasureTime frame
Feasibility of integration of AI assisted cervical pre screening into routine clinical workflow.Timepoint: 4 weeks after the study period.—

Countries

India

Contacts

Public ContactSheena Christabel Pravin

MEDXAI INNOVATIONS PRIVATE LIMITED

sheenachristabelpravin@gmail.com9840506176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026